Prevention of seroma formation after dissection of musculocutaneous flaps.
Dissection of musculocutaneous flaps is uniformly followed by the formation of seroma if drains are not used. Drains can be colonized and form deep tissue infection if left in place for a long time. In this study we investigated whether talc poudrage could prevent the formation of seroma following dissection of the latissimus dorsi muscle in a canine model. Twelve mongrel dogs were randomized into two groups. Group 1 (n = 6) underwent dissection of the left latissimus dorsi muscle which was rotated as a pedicle flap into the left chest through a second intercostal space thoracotomy. The wound was closed in layers without drains. Group 2 (n = 6) had the same procedure, but before closure of the wound, USP talc was applied to the tissues. All animals received cefazolin (500 mg) Q8h for 48 hours perioperatively. Animals were followed for 1-5 months. Wounds with fluctuation were aspirated as many times as necessary and the amount of fluid was recorded. All Group 1 animals developed seromas, in contrast, only one animal in group 2 had a seroma. There was a significant difference in the amount of fluid aspirated for each animal between the two groups (280 +/- 80 in group 1 vs 25 +/- 25 ml in group 2, P < 0.05). The total amount of fluid drained in group 1 was 1730 ml, whereas only 150 ml was aspirated in group 2. Group 1 animals required a total of 11 aspirations to control seromas, in contrast, only one aspiration was needed in group 2. No abscess was identified at postmortem in either group. Based on the results of this study we conclude that talc poudrage can be safely used to minimize seroma formation after dissection of musculocutaneous flaps.
Coons
M S
MS
Department of Surgery, Maimonides Medical Center, Brooklyn, New York 11219.
Folliguet
T A
TA
Rodriguez
C
C
Woloszyn
T T
TT
Tuchler
R E
RE
Marini
C P
CP
D000818:Animals; D002437:Cefazolin / Q000627:therapeutic use; D004285:Dogs; D004322:Drainage / Q000379:methods; D011183:Postoperative Complications / Q000517:prevention & control*; D013524:Surgical Flaps; D013530:Surgical Wound Infection / Q000517:prevention & control; D013627:Talc; D000267:Tissue Adhesions / Q000209:etiology*
D013627:Talc; D002437:Cefazolin